Liposomal and Nanocarrier-Based Delivery of Local Anaesthetics in Postoperative Analgesia
International Journal of Drug Delivery Technology · 20.04.2026 · 16 (14s)
DOI: 10.25258/ijddt.16.14s.76 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 20.04.2026. Verfasst von Dr. Vijul Chawla und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Postoperative pain management remains a critical component of perioperative care, with significant implications for patient recovery, hospital stay, and overall healthcare outcomes. Conventional modes of local anaesthesia tend to possess low action time, systemic toxicity and ineffectual analgesic properties. Local anaesthetics have altered their pharmacodynamics and pharmacokinetics with the evolution of nanotechnology-based delivery of therapeutic means as liposomes, nano emulsions and polymer nanoparticles. They are the new delivery modes which are able to permit sustained drug delivery, compartmental medicine delivery, and reduction in systemic disclosure which is linked with longer analgesia and more safety. The paper provides a comprehensive explanation, insight into the liposomal and nanocarrier system of local anaesthetics introduction in postoperative analgesia. It presents a critical interpretation of the working processes, the formulation plans, clinical practice, and comparative make of nano emulsions, liposomal bupivacaine, and polymeric nanoparticle. The systematic review and synthesis of availed experimental and clinical content analytically will be the research methodology followed by comparative framework evaluation of efficacy, duration, safety and translational feasibility. It can be seen that the liposomal bupivacaine demonstrates an impressive extension of analgesia to 72 hours, but polymeric nanoparticles can be used to maintain controlled and modulated patterns of drug release. There is also nanoemulsions that assist in bio viability and rapidity of effect. The results placed an accent on the excellence of the nanocarrier-written systems as compared to the conventional formulations in the accomplishment of prolonged postoperative analgesia with lesser side effects. The constraints that are available are reviewed and they include complexity of formulation, cost considerations and regulatory challenges. It has concluded the paper that nanocarrier mediated delivery system must be regarded as a revolutionary technology in the management of postoperative pain and there are high chances that the technology will be further integrated into clinical practice and patient-direct analgesics in future.
Zitieren
APA
Chawla, D. V., Rani, D. M., & Kumar, D. K. N. (2026). Liposomal and Nanocarrier-Based Delivery of Local Anaesthetics in Postoperative Analgesia. International Journal of Drug Delivery Technology, 16(14s). https://doi.org/10.25258/ijddt.16.14s.76
Vancouver
Chawla DV, Rani DM, Kumar DKN. Liposomal and Nanocarrier-Based Delivery of Local Anaesthetics in Postoperative Analgesia. International Journal of Drug Delivery Technology. 2026;16(14s). doi:10.25258/ijddt.16.14s.76
BibTeX
@article{Chawla2026,
author = {Chawla, Dr. Vijul and Rani, Dr. Mala and Kumar, Dr. Kosaraju Narendra},
title = {Liposomal and Nanocarrier-Based Delivery of Local Anaesthetics in Postoperative Analgesia},
journal = {International Journal of Drug Delivery Technology},
year = {2026},
volume = {16},
number = {14s},
doi = {10.25258/ijddt.16.14s.76}
}
EUVIMED